RVVQF.US Ravenquest Biomed Inc
- Market cap
- USD 1.24K
- P/E
- -
- P/B
- 0.03x
- ROE
- -61.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2019.
Is RVVQF.US undervalued?
Graham numberThe Graham number of Ravenquest Biomed Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ravenquest Biomed Inc fundamental analysis
No fundamental analysis for Ravenquest Biomed Inc yet.
Ravenquest Biomed Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ravenquest Biomed Inc
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQ…
Full company profileRavenquest Biomed Inc financial statements
2019 annualized: Fiscal year 2019 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jul 31, 2019, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ravenquest Biomed Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 112K | 1.26M | 2.22M |
| Gross Profit | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 14.7K | 801K | 196K |
| Operating Income | -91.6K | -82.1K | -111K | -134K | -105K | -75.9K | -82.7K | -81.5K | -642K | -17.2M | -9.47M |
| EBITDA | -91.6K | -82.1K | -111K | -134K | 292K | 321K | -76.1K | -81.5K | -3.15M | -27.3M | -6.70M |
| Net Income | -90.7K | -82.1K | -85.4K | 101K | -502K | -60.6K | -76.0K | -81.5K | -3.30M | -30.5M | -12.7M |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 | -0.10 | -0.33 | -0.11 |
| Balance Sheet | |||||||||||
| Total Assets | 171K | 454K | 409K | 441K | 40.0K | 13.7K | 8.23K | 8.70K | 8.70M | 37.7M | 39.5M |
| Total Liabilities | 169K | 33.8K | 49.4K | 171K | 272K | 306K | 377K | 459K | 1.13M | 15.3M | 19.0M |
| Shareholders' Equity | 2.08K | 420K | 360K | 270K | -232K | -293K | -369K | -450K | 7.57M | 22.4M | 20.5M |
| Cash & Short-term Investments | 2.13K | 165K | 14.3K | 7.01K | 1.03K | 9.39K | 1.53K | 604.00 | 3.38M | 363K | 749K |
| Total Debt | - | - | - | - | 29.2K | 40.3K | 52.1K | 83.6K | 233K | 13.3M | 14.8M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -42.0K | -168K | -90.1K | -107K | -41.0K | -36.6K | -19.7K | -32.4K | -2.51M | -11.1M | -1.05M |
| Capital Expenditure | 0.00 | 66.8K | 111K | 0.00 | 5.82K | 952.00 | 952.00 | 952.00 | 952.00 | 12.3M | 5.11M |
| Free Cash Flow | -42.0K | -235K | -201K | -107K | -35.1K | -36.6K | -19.7K | -32.4K | -2.51M | -23.4M | -6.16M |
| Ratios | |||||||||||
| ROE | -4,365.0% | -19.5% | -23.8% | 37.2% | - | - | - | - | -43.6% | -136.1% | -61.8% |
| ROA | -53.0% | -18.1% | -20.9% | 22.8% | -1,254.7% | -443.2% | -924.4% | -936.4% | -37.9% | -80.8% | -32.2% |
| Net Profit Margin | - | - | - | - | - | - | - | - | -2,938.1% | -2,423.9% | -572.7% |
| Debt to Equity | - | - | - | - | - | - | - | - | 0.03x | 0.59x | 0.72x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ravenquest Biomed Inc dividends
Ravenquest Biomed Inc has not paid dividends in the last 9 fiscal years.
Who owns Ravenquest Biomed Inc
- Insiders 10.52%
- Institutions 3.23%
- Public & others 86.26%
- Shares outstanding 124M
- Free float 119M
Ravenquest Biomed Inc company profile
- Company name
- Ravenquest Biomed Inc
- Ticker
- RVVQF.US
- ISIN
- CA7543871080
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- October
- Address
- 580 Hornby Street, Vancouver, BC, Canada, V6E 2K3
- Phone
- 877-282-1586
- Website
- rqbglobal.com
About Ravenquest Biomed Inc
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.
Ravenquest Biomed Inc management
5- Mr. David Allen Cross CPA, CGAChief Financial Officer · born 1976
- Mr. Mathieu David McdonaldHead of Corporate Communications · born 1971
- Andy SchinkeHead of Sales & Product Acquisition
- Mr. Shayne TakerHead of Orbital Garden Mfg & Procurement
- Ms. Marla K. RitchieCorporate Secretary · born 1963